# FDA recall D-0706-2022

> **Athenex Pharma Solutions, LLC** · Class II · drug recall initiated 2022-03-14.

## Product

Norepinephrine Bitartrate Injection 4mg per 250 mL in 0.9% Sodium Chloride, 4 mg, 250 mL excel bag, Rx only, Athenex Pharma Solutions, LLC, Clarence, NY, 14031, NDC 76154-474-15

## Reason for recall

Defective container

## Distribution

USA nationwide.

## Key facts

- **Recall number:** D-0706-2022
- **Recalling firm:** Athenex Pharma Solutions, LLC
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2022-03-14
- **Report date:** 2022-03-30
- **Termination date:** 2022-08-04

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Clarence, NY, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0706-2022

## Citation

> AI Analytics. FDA recall D-0706-2022. Retrieved 2026-06-02 from https://api.ai-analytics.org/recall/D-0706-2022. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*